Jerry Tillinger, CEO of US Digestive Health, emphasizes the importance of understanding payers’ focus on reducing costs while managing premium increases, and the need for strong, long-term relationships with commercial payers
Add A Comment
Trending
- GI 2.0: The Playbook | Chapter 8 | The AI-Native GI Practice
- The physician referral black hole is swallowing your growth (BPD)
- Could corporate medicine be on the way out? Inside the new federal bill (MDLinx)
- Retatrutide, a Triple Hormone Receptor Agonist, for Treatment of Obesity (The New England Journal of Medicine)
- Microbiome Holds Biomarker Predictive of CRC Recurrence (GI & Endoscopy News)
- Are You Performing Second Inspection of the Right Colon? (GI & Endoscopy News)
- The AI Is in the Scope. The Evidence Isn’t. (CDO Trends Weekly)
- Updated Diagnostic Criteria for Acute Severe Ulcerative Colitis (Medscape)
